1. Home
  2. BTT vs AMPH Comparison

BTT vs AMPH Comparison

Compare BTT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Municipal 2030 Target Term Trust

BTT

BlackRock Municipal 2030 Target Term Trust

N/A

Current Price

$22.59

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$29.06

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTT
AMPH
Founded
2012
1996
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
BTT
AMPH
Price
$22.59
$29.06
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
★ $24.50
AVG Volume (30 Days)
119.5K
★ 407.8K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 2.95%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.67
Revenue
N/A
★ $719,887,000.00
Revenue This Year
N/A
$3.81
Revenue Next Year
N/A
$4.91
P/E Ratio
★ N/A
$17.44
Revenue Growth
★ N/A
N/A
52 Week Low
$21.30
$16.65
52 Week High
$23.24
$31.00

Technical Indicators

Market Signals
Indicator
BTT
AMPH
Relative Strength Index (RSI) 64.31 68.14
Support Level $22.44 $27.24
Resistance Level $22.72 $29.35
Average True Range (ATR) 0.18 1.11
MACD 0.06 0.23
Stochastic Oscillator 74.06 70.53

Price Performance

Historical Comparison
BTT
AMPH

About BTT BlackRock Municipal 2030 Target Term Trust

Blackrock Municipal 2030 Target Term Trust is a United States-based fixed-term, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to return $25.00 per common share to common shareholders at maturity. The Fund invests the majority of its managed assets in investment-grade municipal securities, the interest of which is exempt from regular federal income tax, and derivatives that provide investment exposure to such securities or to one or more market risk factors associated with such securities.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: